CC BY 4.0 · Thorac Cardiovasc Surg 2025; 73(S 03): e1-e10
DOI: 10.1055/a-2514-7436
Pediatric and Congenital Cardiology

Radiation Exposure during Cardiac Interventions in Congenital Heart Defects: A Multicenter German Registry Analysis 2012–2020

Anja Tengler
1   Division of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilian University of Munich, Munich, Germany
,
Jörg Michel
2   Department of Pediatric Cardiology, Pulmology and Pediatric Intensive Care, University Hospital Tuebingen, Tuebingen, Germany
,
Claudia Arenz
3   German Pediatric Heart Center, University of Bonn, Bonn, Germany
,
UIrike Bauer
4   National Register for Congenital Heart Defects, Berlin, Germany
,
Jens Beudt
4   National Register for Congenital Heart Defects, Berlin, Germany
,
Alexander Horke
5   Division of surgery for Congenital Heart Defects, Department of Cardiac Surgery University of Hannover, Hannover, Germany
,
Gunter Kerst
6   Clinic for Pediatric Cardiology and Congenital Heart Disease, Klinikum Stuttgart, Stuttgart, Germany
,
7   Clinic for Cardiac Surgery and Pediatric Cardiac Surgery, Heart Center Duisburg, Duisburg, Germany
,
2   Department of Pediatric Cardiology, Pulmology and Pediatric Intensive Care, University Hospital Tuebingen, Tuebingen, Germany
› Institutsangaben
Funding The responsible bodies for the registry are the German Society for Thoracic and Cardiovascular Surgery (DGTHG) and the German Society for Pediatric Cardiology and Congenital Heart Defects (DGPK). The registry receives financial support from all participating institutions. In addition, from 2012 to 2016, the registry was funded by the German Heart Foundation (Deutsche Herzstiftung e.V.).

Abstract

Background Interventional cardiac catheterizations have gained major importance in the treatment of congenital heart defects (CHDs). Since patients with CHDs frequently require lifelong medical care and sometimes subsequent invasive treatment, repeated radiation exposure during interventional procedures is a relevant issue concerning potential radiation-related risks. Therefore, a 9-year subanalysis on radiation data during interventional cardiac catheterizations from the German Registry for Cardiac Operations and Interventions in patients with CHDs was performed.

Methods The German Registry for Cardiac Operations and Interventions in Patients with CHDs is a real-world, prospective all-comers database collecting clinical and procedural data on invasive treatment of CHDs. From January 2012 until December 2020, a total of 28,374 cardiac catheter interventions were recorded. For a homogeneous case mix and for obtaining comparable data, eight specified interventions were selected for detailed evaluation. The selected procedures were: atrial septal defect (ASD)/patent foramen ovale (PFO) occlusion, patent ductus arteriosus (PDA) occlusion, ventricular septal defect (VSD) occlusion, coarctation of the aorta (CoA) balloon dilatation and stent implantation, aortic valvuloplasty, pulmonary valvuloplasty, and transcatheter pulmonary valve implantation (TPVI). Data on radiation exposure included total fluoroscopy time (TFT), dose area product (DAP), and DAP per body weight (DAP/BW).

Results The cohort accounted for 9,350 procedures, including 3,426 ASD/PFO occlusions, 2,039 PDA occlusions, 599 aortic and 1,536 pulmonary valvuloplasties, 383 balloon dilatations and 496 stent implantations for CoA, 168 VSD occlusions, and 703 TPVI. Six hundred and ten ASD/PFO procedures (17.8%) were performed without radiation. During the 9-year period, median annual TFT, DAP, and DAP/BW showed a continuous decrease while radiation burden correlated with intervention complexity: For ASD/PFO and PDA occlusion, aortic and pulmonary valvuloplasty as well as balloon dilatation of CoA the median DAP/BW was <20.0 μGy*m2/kg, while median values of 26.3 μGy*m2/kg and 31.6 μGy*m2/kg were noted for stent treatment of CoA and VSD closure, respectively. Radiation burden was highest in TPVI with a median TFT of 23.6 minutes, median DAP of 4,491 μGy*m2, and median DAP/BW of 79.4 μGy*m2/kg.

Conclusion A decrease in radiation exposure was found in eight cardiac interventions from January 2012 to December 2020. Comparison with international registries revealed a good quality of radiation protection. The data underline the requirement of surveillance of radiation burden, especially in this patient group.



Publikationsverlauf

Eingereicht: 25. November 2024

Angenommen: 10. Januar 2025

Accepted Manuscript online:
13. Januar 2025

Artikel online veröffentlicht:
04. März 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Hill KD, Frush DP, Han BK. et al; Image Gently Alliance. Radiation safety in children with congenital and acquired heart disease: a scientific position statement on multimodality dose optimization from the Image Gently Alliance. JACC Cardiovasc Imaging 2017; 10 (07) 797-818
  • 2 Kang SL, Benson L. Recent advances in cardiac catheterization for congenital heart disease. F1000 Res 2018; 7: 370
  • 3 Glatz AC, Patel A, Zhu X. et al. Patient radiation exposure in a modern, large-volume, pediatric cardiac catheterization laboratory. Pediatr Cardiol 2014; 35 (05) 870-878
  • 4 Beauséjour Ladouceur V, Lawler PR, Gurvitz M. et al. Exposure to low-dose ionizing radiation from cardiac procedures in patients with congenital heart disease: 15-year data from a population-based longitudinal cohort. Circulation 2016; 133 (01) 12-20
  • 5 Johnson JN, Hornik CP, Li JS. et al. Cumulative radiation exposure and cancer risk estimation in children with heart disease. Circulation 2014; 130 (02) 161-167
  • 6 Andreassi MG. Radiation risk from pediatric cardiac catheterization: friendly fire on children with congenital heart disease. Circulation 2009; 120 (19) 1847-1849
  • 7 Fazel R, Gerber TC, Balter S. et al; American Heart Association Council on Quality of Care and Outcomes Research, Council on Clinical Cardiology, and Council on Cardiovascular Radiology and Intervention. Approaches to enhancing radiation safety in cardiovascular imaging: a scientific statement from the American Heart Association. Circulation 2014; 130 (19) 1730-1748
  • 8 Gould R, McFadden SL, Hughes CM. Radiation dose in paediatric cardiac catheterisation: A systematic literature review. Radiography (Lond) 2017; 23 (04) 358-364
  • 9 Campolo J, Annoni G, Giaccardi M, Andreassi MG. Congenital heart disease and the risk of cancer: an update on the genetic etiology, radiation exposure damage, and future research strategies. J Cardiovasc Dev Dis 2022; 9 (08) 245
  • 10 Justino H. The ALARA concept in pediatric cardiac catheterization: techniques and tactics for managing radiation dose. Pediatr Radiol 2006; 36 (Suppl. 02) 146-153
  • 11 Harbron RW, Chapple CL, O'Sullivan JJ, Best KE, Berrington de González A, Pearce MS. Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children. Heart 2017; 103 (05) 341-346
  • 12 Lamers LJ, Morray BH, Nugent A, Speidel M, Suntharos P, Prieto L. Multicenter assessment of radiation exposure during pediatric cardiac catheterizations using a novel imaging system. J Interv Cardiol 2019; 2019: 7639754
  • 13 Bergersen L, Gauvreau K, Marshall A. et al. Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv 2011; 4 (02) 188-194
  • 14 Ghelani SJ, Glatz AC, David S. et al. Radiation dose benchmarks during cardiac catheterization for congenital heart disease in the United States. JACC Cardiovasc Interv 2014; 7 (09) 1060-1069
  • 15 Baysson H, Nkoumazok B, Barnaoui S. et al. Follow-up of children exposed to ionising radiation from cardiac catheterisation: the Coccinelle study. Radiat Prot Dosimetry 2015; 165 (1-4): 13-16
  • 16 Quinn BP, Armstrong AK, Bauser-Heaton HD. et al; Congenital Cardiac Catheterization Project on Outcomes-Quality Improvement (C3PO-QI). Radiation risk categories in cardiac catheterization for congenital heart disease: a tool to aid in the evaluation of radiation outcomes. Pediatr Cardiol 2019; 40 (02) 445-453
  • 17 Quinn BP, Cevallos P, Armstrong A. et al. Longitudinal improvements in radiation exposure in cardiac catheterization for congenital heart disease: a prospective multicenter C3PO-QI study. Circ Cardiovasc Interv 2020; 13 (05) e008172
  • 18 Manica JL, Duarte VO, Ribeiro M. et al. Standardizing radiation exposure during cardiac catheterization in children with congenital heart disease: data from a multicenter Brazilian registry. Arq Bras Cardiol 2020; 115 (06) 1154-1161
  • 19 Jacobs JP, Krasemann T, Herbst C. et al. Combining Congenital heart surgical and interventional cardiology outcome data in a single database: The Development of a Patient-Centered Collaboration of the European Congenital Heart Surgeons Association (ECHSA) and the Association for European Paediatric and Congenital Cardiology (AEPC). Cardiol Young 2023; 33 (07) 1043-1059
  • 20 Beckmann A, Dittrich S, Arenz C. et al; German Quality Assurance / Competence Network for Congenital Heart Defects Investigators. German Registry for cardiac operations and interventions in patients with congenital heart disease: report 2020-Comprehensive Data from 6 Years of Experience. Thorac Cardiovasc Surg 2021; 69 (S 03): e21-e31
  • 21 Dittrich S, Arenz C, Krogmann O. et al. German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease: Report 2021 and 9 Years' Longitudinal Observations on Fallot and Coarctation Patients. Thorac Cardiovasc Surg 2022; 70 (S 03): e21-e33
  • 22 Hofbeck M, Arenz C, Bauer U. et al. German Registry for cardiac operations and interventions in CHD: Annual Report 2022. Thorac Cardiovasc Surg 2024; 72 (S 03): e16-e29
  • 23 Hoffmann W, Latza U, Baumeister SE. et al. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol 2019; 34 (03) 301-317
  • 24 European Medicines Agency. Guideline for Good Clinical Practice. Accessed January 17, 2025 at: https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice
  • 25 World Medical Association. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. Accessed January 11, 2021 at: https://www.wma.net/policies-post/wma-declaration-of-helsinki/
  • 26 Franklin RCG, Béland MJ, Colan SD. et al. Nomenclature for congenital and paediatric cardiac disease: the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11). Cardiol Young 2017; 27 (10) 1872-1938
  • 27 Jacobs JP, Franklin RCG, Béland MJ. et al. Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11). Cardiol Young 2021; 31 (07) 1057-1188
  • 28 Cevallos PC, Armstrong AK, Glatz AC. et al. Radiation dose benchmarks in pediatric cardiac catheterization: a prospective multi-center C3PO-QI study. Catheter Cardiovasc Interv 2017; 90 (02) 269-280
  • 29 Goldstein BH, Bergersen L, Armstrong AK. et al. Adverse events, radiation exposure, and reinterventions following transcatheter pulmonary valve replacement. J Am Coll Cardiol 2020; 75 (04) 363-376
  • 30 Bergmann M, Germann CP, Nordmeyer J, Peters B, Berger F, Schubert S. Short- and long-term outcome after interventional vsd closure: a single-center experience in pediatric and adult patients. Pediatr Cardiol 2021; 42 (01) 78-88
  • 31 Schubert S, Kainz S, Peters B, Berger F, Ewert P. Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clin Res Cardiol 2012; 101 (09) 691-700
  • 32 Nordmeyer J, Ewert P, Gewillig M. et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J 2019; 40 (27) 2255-2264
  • 33 McElhinney DB, Zhang Y, Levi DS. et al. Reintervention and survival after transcatheter pulmonary valve replacement. J Am Coll Cardiol 2022; 79 (01) 18-32
  • 34 Lehner A, Dashkalova T, Ulrich S. et al. Intermediate outcomes of transcatheter pulmonary valve replacement with the Edwards Sapien 3 valve - German experience. Expert Rev Med Devices 2019; 16 (09) 829-834
  • 35 Jin Q, Long Y, Zhang G. et al. Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract. Catheter Cardiovasc Interv 2024; 103 (02) 359-366
  • 36 Sitefane F, Malekzadeh-Milani S, Villemain O, Ladouceur M, Boudjemline Y. Reduction of radiation exposure in transcatheter atrial septal defect closure: how low must we go?. Arch Cardiovasc Dis 2018; 111 (03) 189-198
  • 37 Kubicki R, Hummel J, Höhn R, Müller K, Stiller B, Grohmann J. Catheter strategy to ease the procedure and reduce radiation exposure when requiring neck access. Open Heart 2020; 7 (01) e001267